Our findings that matrisome‐associated proteins may serve as key biomarkers have been recently corroborated by other studies from multiple patient cohorts showing that the levels of SMOC1 and other matrisome proteins are easily detectable and highly altered in AD CSF and plasma samples, even decades before the first AD symptoms appear.41, 71. This evidence concerns the gene SMOC1 and Alzheimer disease.